Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter H Moolenaar

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Trends in Cancer|March 17, 2024
Tumor immune escape by autotaxin: keeping eosinophils at bayElisa Matas-Rico, Wouter H Moolenaar
Immunity|August 13, 2025
How does lipid phosphatase 1 (LPP1) regulate antitumor CD8<sup>+</sup> T cell activity?Andrew J Morris, Wouter H Moolenaar
Cancer Metastasis Reviews|October 18, 2011
Autotaxin and LPA receptor signaling in cancerAnna J S Houben, Wouter H Moolenaar
Progress in Lipid Research|April 27, 2007
Regulation and biological activities of the autotaxin-LPA axisLaurens A van Meeteren, Wouter H Moolenaar
BMC Genomics|August 16, 2008
Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profilingCatelijne Stortelers, Ron Kerkhoven, Wouter H Moolenaar
Advances in Biological Regulation|October 17, 2012
Structure-function relationships of autotaxin, a secreted lysophospholipase DJens Hausmann, Anastassis Perrakis, Wouter H Moolenaar
The Journal of Investigative Dermatology|March 9, 2007
Upregulation of cytokine expression in fibroblasts exposed to loxosceles sphingomyelinase D: what is the trigger?Laurens A van Meeteren, Catelijne Stortelers, Wouter H Moolenaar
Cell Cycle (Georgetown, Tex.)|November 19, 2016
Neuronal differentiation through GPI-anchor cleavageElisa Matas-Rico, Michiel van Veen, Wouter H Moolenaar
Anti-Cancer Agents in Medicinal Chemistry|March 18, 2014
Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlookMarcel Verheij, Wouter H Moolenaar, Wim J van Blitterswijk
Oncotarget|December 29, 2016
GDE2/GDPD5 in neuroblastomaElisa Matas-Rico, Michiel van Veen, Wouter H Moolenaar
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Trends in Cancer|March 17, 2024
Tumor immune escape by autotaxin: keeping eosinophils at bayElisa Matas-Rico, Wouter H Moolenaar
Immunity|August 13, 2025
How does lipid phosphatase 1 (LPP1) regulate antitumor CD8<sup>+</sup> T cell activity?Andrew J Morris, Wouter H Moolenaar
Cancer Metastasis Reviews|October 18, 2011
Autotaxin and LPA receptor signaling in cancerAnna J S Houben, Wouter H Moolenaar
Progress in Lipid Research|April 27, 2007
Regulation and biological activities of the autotaxin-LPA axisLaurens A van Meeteren, Wouter H Moolenaar
BMC Genomics|August 16, 2008
Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profilingCatelijne Stortelers, Ron Kerkhoven, Wouter H Moolenaar
Advances in Biological Regulation|October 17, 2012
Structure-function relationships of autotaxin, a secreted lysophospholipase DJens Hausmann, Anastassis Perrakis, Wouter H Moolenaar
The Journal of Investigative Dermatology|March 9, 2007
Upregulation of cytokine expression in fibroblasts exposed to loxosceles sphingomyelinase D: what is the trigger?Laurens A van Meeteren, Catelijne Stortelers, Wouter H Moolenaar
Cell Cycle (Georgetown, Tex.)|November 19, 2016
Neuronal differentiation through GPI-anchor cleavageElisa Matas-Rico, Michiel van Veen, Wouter H Moolenaar
Anti-Cancer Agents in Medicinal Chemistry|March 18, 2014
Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlookMarcel Verheij, Wouter H Moolenaar, Wim J van Blitterswijk
Oncotarget|December 29, 2016
GDE2/GDPD5 in neuroblastomaElisa Matas-Rico, Michiel van Veen, Wouter H Moolenaar
Pageof 8